View Older Stories View More Recent Stories

Oct 29, 2025 04:13PM BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 7c
Oct 28, 2025 06:41AM BridgeBio Pharma (BBIO) PT Raised to $80 at H.C. Wainwright
Oct 27, 2025 01:30PM BridgeBio Pharma (BBIO) PT Raised to $69 at Raymond James
Oct 27, 2025 10:22AM BridgeBio Pharma (BBIO) PT Raised to $68 at Leerink Partners
Oct 27, 2025 09:20AM BridgeBio Pharma (BBIO) PT Raised to $90 at Evercore ISI
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'
Sep 30, 2025 08:01AM Piper Sandler Sees 'A Good Setup for BridgeBio Pharma (BBIO) Shares to Outperform'
Sep 23, 2025 08:48AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 22, 2025 09:09AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Cites Confidence in Attruby
Sep 15, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 12, 2025 09:01AM BridgeBio Pharma (BBIO) PT Raised to $82 at UBS on ADH1 Optimism
Sep 11, 2025 08:55AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Optimistic on Encaleret
Sep 10, 2025 02:38PM TD Cowen on BridgeBio Pharma (BBIO): 'We anticipate an approval in 2026 with peak sales approaching $1B'
Sep 10, 2025 10:26AM Truist Securities Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 10, 2025 10:00AM Jefferies Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 8, 2025 07:12AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) Added to JPMorgan Positive Catalyst Watch List
Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) PT Raised to $70 at JPMorgan
Sep 2, 2025 06:56AM BridgeBio Pharma (BBIO) PT Raised to $70 at H.C. Wainwright
Aug 6, 2025 01:51PM TD Cowen on BridgeBio Pharma (BBIO): 'Attruby Is a Winner'
Aug 6, 2025 06:07AM BridgeBio Pharma (BBIO) PT Raised to $61 at Oppenheimer
Aug 5, 2025 05:47PM BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 20c
Jul 29, 2025 04:24PM Raymond James Assumes BridgeBio Pharma (BBIO) at Outperform
Jul 29, 2025 08:25AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Jul 23, 2025 07:31AM BridgeBio study finds ADH1 genetic condition underdiagnosed by 80%
Jul 21, 2025 07:29AM Truist Securities Starts BridgeBio Pharma (BBIO) at Buy
Jul 18, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 14, 2025 05:46AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 14, 2025 12:54AM Jefferies Starts BridgeBio Pharma (BBIO) at Buy
Jul 11, 2025 07:45AM Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
Jul 9, 2025 06:04AM Oppenheimer Upgrades BridgeBio Pharma (BBIO) to Outperform
Jul 3, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 02:27PM Raymond James Reiterates Outperform Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 10:57AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 07:30AM BridgeBio Pharma (BBIO) Raises $300 Million Through Partial Capped Monetization of BEYONTTRA European Royalty
Jun 17, 2025 05:53AM Wolfe Research Starts BridgeBio Pharma (BBIO) at Outperform
Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 6, 2025 07:27AM Piper Sandler Highlights an 'Under-The-Radar 2H25 Catalyst' at BridgeBio Pharma (BBIO)
Jun 4, 2025 09:05AM BridgeBio Pharma (BBIO) PT Raised to $42 at BMO Capital
May 25, 2025 03:00PM Biotech stocks Q1 earnings review
May 19, 2025 12:37PM BridgeBio Pharma Inc. (BBIO): Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
May 13, 2025 07:31AM BridgeBio Pharma Inc. (BBIO): First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
Apr 30, 2025 03:25PM BridgeBio Pharma Inc. (BBIO) call put ratio 1.2 calls to 1 put with a focus on May calls and puts as share price up 4.5%
Apr 30, 2025 07:20AM BridgeBio Pharma (BBIO) PT Raised to $55 at Scotiabank
Apr 30, 2025 01:42AM BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 3c
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 07:31AM Piper Sandler on BridgeBio Pharma (BBIO): 'Attruby Launch In Early Innings Looks Strong'
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Apr 1, 2025 06:41AM Raymond James Reiterates Outperform Rating on BridgeBio Pharma (BBIO)
View More Recent Stories View Older Stories